image

The best stocks to buy since 1993

Our latest issue will be released in 6 days, don't miss out!

Revolution Beauty - Business goes up for sale

July 2025

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • REVB
  • Price:
  • 4.7p
Mike Ashley’s Frasers initially made a preliminary bid approach for Revolution but later withdrew its interest. Since then, Revolution has launched a formal sale process and opened its books to other parties. Q1 has seen softer-than-anticipated trading in both the US market and digital channels. The benefits from the planned rationalisation of the SKU base have yet to materialise. Cavendish forecasts lower revenue of £126m for this year, with a return to growth projected in FY27 to £132.3m. A corresponding pre-tax loss of £0.1m is expected to turn into a profit of £1.4m. Panmure Liberum is managing the sale process and is said to have received interest from “a number of” buyers. Although Ashley has been a difficult counterp ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe